Gilead Sciences

+$0.57 (+0.90%) Today
-$0.01 (-0.02%) As of 12:00 AM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell GILD and other ETFs, options, and stocks.

About GILD

Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases.

CEO
Daniel P. O'Day
Employees
14,400
Headquarters
Foster City, California
Founded
1987

GILD Key Statistics

Market cap
80.08B
Price-Earnings ratio
17.83
Dividend yield
4.48
Average volume
8.55M
High today
$63.90
Low today
$62.73
Open price
$63.27
Volume
6.81M
52 Week high
$74.12
52 Week low
$57.19

GILD News

MarketWatchMay 16

Gilead Sciences Says FDA Lifts Clinical Hold On Injectable Lenacapavir - MarketWatch

By Denny Jacob Gilead Sciences Inc. said Monday that the Food and Drug Administration lifted a clinical hold placed on the company's investigational new drug a

GILD Earnings

$0.00
$0.88
$1.77
$2.65
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Estimated
— per share
Actual
Expected Jul 28, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure